Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2
KCE Reports 243 (2015)
Please take note of the publication date of this guideline. From a methodological point of view, a guideline is generally considered obsolete after 5 years. It is therefore possible that some parts of this document are no longer relevant. |
How to refer to this report
Robays Jo, Stordeur Sabine, Hulstaert Frank, Baurain Jean-François, Brochez Lieve, Caplanusi Teofila, Claes Kathleen, Legius Eric, Rottey Sylvie, Schrijvers Dirk, t'Kint de Roodenbeke Daphné, van Maerken Tom, Ullman Urielle, Poppe Kris. Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2. Good Clinical Practice (GCP). Brussels. Belgian Health Care Knowledge Centre (KCE). 2015. KCE Reports 243. DOI: 10.57598/R243C.